A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects

A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study of the Safety, Tolerability and Pharmacokinetics of ABT-102 in Healthy Subjects

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of three different strengths of an investigational product dosed twice a day over 7 days in healthy subjects.

Inclusion Criteria:

• Males and Females with a condition of general good health.
• Must be willing to participate in all study-related procedures.

Exclusion Criteria:

• History of significant sensitivity to any drug.
• Allergy to soy lecithin, soybeans, soybean oil, or other soybean derivatives.
• A requirement for medications, vitamins and/or herbal supplements during the study.
• Pregnant or breast-feeding.
• History of drug or alcohol abuse.
• Positive Hepatitis or HIV test.
• History of certain medical conditions or any uncontrolled medical illness.
• History of certain gastrointestinal surgeries that may interfere with gastrointestinal motility, PH or absorption.
• Current participation in another clinical study or receipt of investigational drug within the past 6 weeks.